Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide

Surgery Today

Volumn 27, Issue 7, 1997, Pages 676-679

  Sakakura, Chouhei ^a   Sweeney, Elizabeth A ^a   Shirahama, Tsutomu ^a   Igarashi, Yasuyuki ^a   Hakomori, Sen Ichiroh ^a   Tsujimoto, Hiroyuki ^b   Imanishi, Tsutomu ^b   Ogaki, Masaharu ^b   Ohyama, Takayuki ^b   Yamazaki, Junya ^b   Hagiwara, Akeo ^b   Yamaguchi, Toshiharu ^b   Sawai, Kiyoshi ^b   Takahashi, Toshio ^b  

^a The Biomembrane Institute   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bax; Breast cancer; Chemosensitivity

Indexed keywords

CISPLATIN; ETOPOSIDE;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL SURVIVAL; CISPLATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETOPOSIDE; GENE EXPRESSION; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 9844226787     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02388231     Document Type: Article

References (12)

1. Chiou SK, Rao L, White E (1994) Bcl-2 blocks p53 dependent apoptosis. Mol Cell Biol 14:2556-2563
2. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967
3. Nunez G, Clarke MF (1994) The Bcl-2 fmaily of proteins: regulators of cell death and survival. Trends Cell Biol 4:399-403
4. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di-Fronzo G, Rilke F, Veronesi U (1994) The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. 5 J Natl Cancer Inst 86:499-504
5. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54:3253-3259
6. Kamesaki S, Kamesaki H, Jorgensen TJ, Tanizawa A, Pommier Y, Cossman J (1993) bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res 53:4251-4256
7. Korsmeryer SJ (1992) Bcl-2: an antidote to programmed cell death. Cancer Surv 15:105-118
8. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerize in vivo with a conserved homologue, bax, that accelerates programmed cell death. Cell 74:609-619
9. Bargou R, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Doreken B (1995) Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60:854-859
10. Zhan Q, Fan S, Bae I, Guilouf C, Liebermann DA, O'connor PM, Fornace AJ Jr (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743-3751
11. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
12. Sumantran VN, Ealovega MW, Nunez G, Clarke MF, Wicha MS (1995) Overexpression of bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55:2507-2510